⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KLRS News
Kalaris Therapeutics, Inc. Common Stock
Kalaris Reports Full Year 2025 Financial Results and Provides Business Updates
globenewswire.com
KLRS
Form 8-K
sec.gov
KLRS
Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting
globenewswire.com
KLRS
Kalaris Therapeutics Announces Oversubscribed $50.0 Million Private Placement
globenewswire.com
KLRS
Kalaris Therapeutics Reports Positive Initial Phase 1a Data for TH103 in Treatment-Naïve Neovascular AMD
globenewswire.com
KLRS
Kalaris to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference
newsfilecorp.com
KLRS
Kalaris Reports Third Quarter 2025 Financial Results and Provides Business Updates
globenewswire.com
KLRS
Kalaris to Present at Stifel 2025 Annual Healthcare Conference
globenewswire.com
KLRS